微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.03% | -93.33% | 100.2% | 59/71 | 2.21% | ST目药 | 9.27% | 行业排名> |
| 2024-12-31 | -15.2% | -584.68% | -2048.72% | 63/71 | 3.08% | ST目药 | 22.26% | 行业排名> |
| 2024-09-30 | 0.78% | 4000% | 232.2% | 55/71 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | -0.59% | -126.92% | -231.11% | 59/71 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.45% | 4600% | 120.27% | 58/71 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | -2.22% | 3.9% | -11000% | 61/71 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | -0.02% | -105.56% | 92.31% | 60/71 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | -0.26% | 35% | -2500% | 61/71 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | -0.01% | -109.09% | 99.57% | 63/71 | 2.65% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | -2.31% | -219.07% | -741.67% | 58/71 | 7.39% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 0.36% | -93.57% | 190% | 61/71 | 5.07% | 片仔癀 | 19.69% | 行业排名> |
| 2022-06-30 | -0.4% | -113.56% | -463.64% | 62/71 | 3.13% | 片仔癀 | 12.75% | 行业排名> |
| 2022-03-31 | 0.11% | -93.57% | -94.33% | 63/71 | 2.15% | 片仔癀 | 6.88% | 行业排名> |
| 2021-12-31 | 1.94% | -40.31% | -65.36% | 57/71 | 4.45% | 片仔癀 | 27.39% | 行业排名> |
| 2021-09-30 | 5.6% | 49.73% | 89.83% | 45/71 | 7.44% | 片仔癀 | 23.14% | 行业排名> |
| 2021-06-30 | 2.95% | 83.23% | 72.51% | 52/71 | 4.61% | 片仔癀 | 13.23% | 行业排名> |
| 2021-03-31 | 1.71% | 52.68% | -47.38% | 44/71 | -2.87% | *ST长药 | 7.37% | 行业排名> |
| 2020-12-31 | 3.25% | 38.89% | -13.1% | 49/71 | -2.08% | 沃华医药 | 22.84% | 行业排名> |
| 2020-09-30 | 3.74% | 42.75% | 132.3% | 50/71 | 5.56% | 沃华医药 | 19.47% | 行业排名> |
| 2020-06-30 | 1.61% | -17.44% | 43.75% | 52/71 | 3.25% | 沃华医药 | 12.7% | 行业排名> |
| 2020-03-31 | 1.12% | 16.67% | -52.14% | 49/71 | 1.91% | 济川药业 | 7.33% | 行业排名> |
| 2019-12-31 | 2.34% | 174.76% | -10.69% | 53/71 | 3.89% | 济川药业 | 27.43% | 行业排名> |
| 2019-09-30 | 2.62% | 138.18% | 34.36% | 53/71 | 7.09% | 济川药业 | 23.05% | 行业排名> |
| 2019-06-30 | 1.95% | 26.62% | 103.13% | 52/71 | 4.58% | 济川药业 | 15.79% | 行业排名> |
| 2019-03-31 | 0.96% | 6.67% | 130.67% | 54/71 | 2.86% | 华润三九 | 10.23% | 行业排名> |
| 2018-12-31 | -3.13% | -162.48% | -384.55% | 64/71 | 7.68% | 济川药业 | 32.79% | 行业排名> |
| 2018-09-30 | 1.1% | -75.72% | -28.57% | 62/71 | 7.89% | 济川药业 | 27.55% | 行业排名> |
| 2018-06-30 | 1.54% | -42.75% | 71.11% | 56/71 | 4.92% | 济川药业 | 17.62% | 行业排名> |
| 2018-03-31 | 0.9% | -16.67% | -82.04% | 56/71 | 2.71% | 济川药业 | 10.07% | 行业排名> |
| 2017-12-31 | 5.01% | -9.24% | 10.6% | 52/71 | 9.76% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-09-30 | 4.53% | -4.63% | 68.4% | 52/71 | 8.29% | 济川药业 | 24.2% | 行业排名> |
| 2017-06-30 | 2.69% | 94.93% | 149.07% | 52/71 | 5.16% | *ST大药 | 15.31% | 行业排名> |
| 2017-03-31 | 1.08% | 25.58% | -80.43% | 48/71 | 2.6% | 济川药业 | 14.64% | 行业排名> |
| 2016-12-31 | 5.52% | 160.38% | 16.21% | 53/71 | 9.95% | 济川药业 | 7.64% | 行业排名> |
| 2016-09-30 | 4.75% | 186.14% | 244.2% | 46/71 | 9.31% | 维康药业 | 38.23% | 行业排名> |
| 2016-06-30 | 1.38% | 40.82% | 60.47% | 58/71 | 5.02% | 太极集团 | 58.41% | 行业排名> |
| 2016-03-31 | 0.86% | 79.17% | -59.43% | 50/71 | 4.04% | 新光药业 | 16.54% | 行业排名> |
| 2015-12-31 | 2.12% | 103.85% | 27.71% | 58/71 | 11.27% | 太极集团 | 71.6% | 行业排名> |
| 2015-09-30 | 1.66% | 50.91% | 69.39% | 51/71 | 8.43% | 维康药业 | 48.67% | 行业排名> |
| 2015-06-30 | 0.98% | 44.12% | 104.17% | 52/71 | 5.48% | 济川药业 | 21.37% | 行业排名> |
| 2015-03-31 | 0.48% | -14.29% | -53.85% | 51/71 | 2.93% | 贵州三力 | 15.84% | 行业排名> |